Status:
UNKNOWN
Povidone-Iodine Rinses as an Adjuvant Therapy Post-Operatively
Lead Sponsor:
St. Paul's Hospital, Canada
Conditions:
Chronic Rhinosinusitis (Diagnosis)
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Povidone Iodine solution is a nasal antiseptic. Its application has been shown to be clinically safe, tolerable and effective against bacteria and fungi associated with chronic rhinosinusitis. The pu...
Detailed Description
Background and scientific rationale Chronic rhinosinusitis (CRS) is an inflammatory condition of the paranasal sinuses affecting millions of patients, resulting in billions of dollars being spent annu...
Eligibility Criteria
Inclusion
- 19 years or older
- Undergoing FESS at St. Paul's Hospital or False Creek Surgical Centre
Exclusion
- Patients with sinonasal tumors.
- Patients who previously used PVP-I rinses - Patients with autoimmune diseases affecting the upper airway
- eg Systemic lupus erythematosus, Sjögren's syndrome, systemic sclerosis etc.
- Immuno-compromised patients, and patients with impairment in mucociliary function
- (e.g., cystic fibrosis, Kartagener syndrome)
- Hypersensitivity to iodine
- History of thyroid disorders including thyroid cancer, hyperthyroidism and hypothyroidism
- Use of medications for thyroid disorders including thyroxine and carbimazole
- Pregnancy
- Patients unable to speak English.
Key Trial Info
Start Date :
February 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 10 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04278950
Start Date
February 10 2020
End Date
February 10 2021
Last Update
February 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.